High angiotensin II state without cardiac remodeling (Bartter’s and Gitelman’s syndromes): Are angiotensin II type 2 receptors involved? (original) (raw)
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322: 1561–6. ArticleCASPubMed Google Scholar
Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 2005, 23: S27–33. ArticleCASPubMed Google Scholar
Mehta PK, Griendling KK. Angiotensin II Cell Signaling. Physiological and Pathological Effects in the Cardiovascular System. Am J Physiol Cell Physiol 2007, 92: C82–97. Google Scholar
Devereux RB, Dahlöf B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial. Circulation 2004, 110: 1456–62. ArticleCASPubMed Google Scholar
Schmieder RE, Martus P, and Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta analysis of randomized double-blind studies. JAMA 1996, 275: 1507–13. ArticleCASPubMed Google Scholar
Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter’s and Gitelman’s syndromes: from gene to clinic. Nephron Physiol 2004, 96: 65–78. Article Google Scholar
Calò LA. Vascular tone control in humans: the utility of studies in Bartter’s/Gitelman’s syndromes. Kidney Int 2006, 69: 963–6. ArticlePubMed Google Scholar
Calò LA, Pessina AC. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007, 25: 259–64. ArticlePubMed Google Scholar
Calò LA, Puato M, Schiavo S, et al. Absence of vascular remodeling in a high angiotensin II state (Bartter’s and Gitelman’s syndromes). Implications for angiotensin II signaling pathways. Nephrol Dial Transplant 2008, 23: 2804–9. ArticlePubMed Google Scholar
O’Regan S, Heitz F, Davignon A. Echocardiography assessment of left ventricular function in patients with hypokalemia. Miner Electrolyte Metab 1985, 11: 1–4. PubMed Google Scholar
Calò L, Scognamiglio R, Nistri S, et al. Evidence of myocardial dysfunction in Bartter’s syndrome. Am J Nephrol 1997, 17: 124–7. ArticlePubMed Google Scholar
Foglia PE, Bettinelli A, Tosetto C, et al. Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant 2004, 19: 1398–402. ArticlePubMed Google Scholar
Calo LA, Pagnin E, Davis PA, et al. Increased Expression of Regulator of G Protein Signaling-2 (RGS-2) in Bartter’s/Gitelman’s Sydrome. A Role in the Control of Vascular Tone and Implication for Hypertension. J Clin Endocrinol Metab 2004, 89: 4153–7. ArticleCASPubMed Google Scholar
Calò LA, Pagnin E, Ceolotto G, et al. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter’s/Gitelman’s syndromes. J Hypertens 2008, 26: 938–45. ArticlePubMed Google Scholar
Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2: 358–67. ArticleCASPubMed Google Scholar
Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57: 450–8. ArticleCASPubMed Google Scholar
Dzau VJ and Lopez-Ilasaca M. Searching for transcriptional regulators of Ang II-induced vascular pathology. J Clin Invest 2005, 115: 2319–22. ArticleCASPubMed CentralPubMed Google Scholar
Zhan Y, Brown C, Maynard E, et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005, 115: 2508–16. ArticleCASPubMed CentralPubMed Google Scholar
Calò LA, Pagnin E, Davis PA, Sartori M, Semplicini A. Oxidative stress related factors in Bartter’s and Gitelman’s syndromes: relevance for Angiotensin II signalling. Nephrol Dial Transplant 2003, 18: 1518–25. ArticlePubMed Google Scholar
Calò L, Ceolotto G, Milani M, et al. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int 2001, 60: 882–9. ArticlePubMed Google Scholar
Calo L, Davis PA, Semplicini A. Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity. Kidney Int 2002, 61: 353–4. ArticlePubMed Google Scholar
Wieland T, Lutz S, Chidiac P. Regulators of G protein signaling: a spotlight on emerging functions in the cardiovascular system. Curr Opin Pharmacol 2007, 7: 1–7. Article Google Scholar
Semplicini A, Lenzini L, Sartori M, et al. Reduced expression of regulator of G protein signaling-2 in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens 2006, 24: 1115–24. ArticleCASPubMed Google Scholar
Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular diseases? J Hypertens 2003, 21: 1429–43. ArticleCASPubMed Google Scholar
Hansen JL, Servant G, Baranski TJ, Fujita T, Iiri T, Sheikh SP. Functional reconstitution of the angiotensin II type 2 receptor and Gi activation. Circ Res 2000, 87: 753–9. ArticleCASPubMed Google Scholar
Abadir PM, Periasamy A, Carey RM, Siragy HM. Angiotensin II type 2 receptor bradykinin B2 receptor functional heterodimerization. Hypertension 2006, 48: 316–22. ArticleCASPubMed Google Scholar
Calo L, Davis PA, Milani M, et al. Increased endothelial nitric oxide synthase mRNA level in Bartter’s and Gitelman’s syndrome. Relationship to vascular reactivity. Clin Nephrol 1999, 51: 12–7. CASPubMed Google Scholar
Calo L, D’Angelo A, Cantaro S, et al. Increased urinary NO2-/NO3- and cyclic GMP levels in patients with Bartter’s syndrome: relationship to vascular reactivity. Am J Kidney Dis 1996, 27: 874–9. Article Google Scholar
Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC, Calo LA. Rho kinase and PAI-1 in Bartter’s/Gitelman’s syndromes: relationship to angiotensin II signaling. J Hypertens 2004, 22: 1963–9. ArticleCASPubMed Google Scholar
Pagnin E, Semplicini A, Sartori M, Pessina AC, Calo LA. Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter’s and Gitelman’s syndromes. Relevance for the pathophysiology of hypertension. Am J Hypertens 2005, 18: 1200–5. ArticleCASPubMed Google Scholar
Savoia C, Tabet F, Yao G, Schiffrin E, Touyz R. Negative regulation of Rho/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005, 23: 1037–45. Google Scholar
Kurisu S, Ozono R, Oshima T, et al. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003, 41: 99–107. ArticleCASPubMed Google Scholar